Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Organoïde cortical en microscopie confocale

Cellular and molecular neurobiology

Research Area

Last update: 05/03/2026 Reading time: 1min
Retour à la recherche

The main objective of the teams in this area is to identify the genetic, molecular and cellular mechanisms that underlie brain function during development and aging.

This fundamental knowledge is essential for understanding major brain functions and neurological and psychiatric diseases in order to develop new therapeutic targets.

Mobilization of teams

Mobilization of teams

Paris Brain Institute teams in molecular and cellular neuroscience are engaged in a collaborative effort to understand normal brain and spinal cord development and the causes of their dysfunction in aging and neurological diseases (neurodegenerative diseases, multiple sclerosis, epilepsy, brain tumours, etc.).

Paris Brain Institute strategy is to assess the influence of genetics, dissect the molecular machinery of intracellular signaling, elucidate the role of different cell types, and understand complex cellular interactions in the normal or pathological state. The elucidation of the molecular and cellular bases of disorders of the nervous system allows us to understand the mechanisms of diseases and to develop new approaches to diagnose and treat them.

News that might interest you

Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
See all our news